|BTIG Research||Robert (Bert) Hazlett|
|Cantor Fitzgerald||Louise Chen|
|HC Wainwright||Ed Arce|
|Ladenburg Thalmann||Kevin DeGeeter|
|Leerink Partners||Paul Matteis|
|LifeSci Advisors||David Sherman|
Paratek Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Paratek Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Paratek Pharmaceuticals, Inc. or its management. Paratek Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.